Gruppo FarmaImpresa at the Top of European Quality: Maximum Safety for Gynecologic Well-Being The EU Regulation 2017/745 (MDR) is Europe’s most stringent framework for manufacturing and marketing medical devices. It raises the bar on safety, quality, and traceability, introducing far stricter requirements than previous directives. For Gruppo FarmaImpresa, obtaining MDR certification for the Class IIb…
Medical device based on 3% Boric Acid for the treatment of vaginal infections and dryness: results after 4 weeks of treatment Vaginal infections, particularly those caused by Candida albicans, represent one of the main causes of intimate discomfort in women, with recurrent episodes that significantly affect daily well-being and quality of life. To meet this…
Vaginal Gel: Registered Medical Device in UK for Women’s Intimate Well-Being We are pleased to announce the official registration with the relevant authorities in the UK of a Class II medical device, compliant with MDD regulations. This is a vaginal gel with a pH of 4.5, packaged in practical 5 ml tubes (6 tubes per…
What are the different characteristics of the vaginal microbiome (VMB) between patients with polycystic ovary syndrome (PCOS) and healthy women? A cross-sectional study was conducted in a single university-affiliated academic center. 1446 participants were recruited the group with polycystic ovary syndrome consisting of 713 people and the control group consisting of 733 people. Vaginal swabs…